1. Home
  2. XLO vs DIT Comparison

XLO vs DIT Comparison

Compare XLO & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

N/A

Current Price

$9.04

Market Cap

56.9M

Sector

Health Care

ML Signal

N/A

Logo AMCON Distributing Company

DIT

AMCON Distributing Company

HOLD

Current Price

$67.56

Market Cap

64.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XLO
DIT
Founded
2016
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Food Distributors
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
56.9M
64.4M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
XLO
DIT
Price
$9.04
$67.56
Analyst Decision
Buy
Analyst Count
1
0
Target Price
★ $28.00
N/A
AVG Volume (30 Days)
★ 9.2K
247.0
Earning Date
05-14-2026
04-20-2026
Dividend Yield
N/A
★ 0.74%
EPS Growth
N/A
★ N/A
EPS
N/A
★ 1.40
Revenue
$43,766,000.00
★ $1,392,388,157.00
Revenue This Year
N/A
N/A
Revenue Next Year
$168.77
N/A
P/E Ratio
★ N/A
$48.26
Revenue Growth
★ 589.88
5.30
52 Week Low
$0.46
$59.15
52 Week High
$9.90
$122.00

Technical Indicators

Market Signals
Indicator
XLO
DIT
Relative Strength Index (RSI) 48.64 47.94
Support Level $8.63 $59.15
Resistance Level $9.15 $74.55
Average True Range (ATR) 0.24 0.53
MACD 0.00 0.39
Stochastic Oscillator 21.83 35.74

Price Performance

Historical Comparison
XLO
DIT

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

Share on Social Networks: